1. Home
  2. GPCR vs WABC Comparison

GPCR vs WABC Comparison

Compare GPCR & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • WABC
  • Stock Information
  • Founded
  • GPCR 2016
  • WABC 1972
  • Country
  • GPCR United States
  • WABC United States
  • Employees
  • GPCR N/A
  • WABC 641
  • Industry
  • GPCR
  • WABC Major Banks
  • Sector
  • GPCR
  • WABC Finance
  • Exchange
  • GPCR Nasdaq
  • WABC Nasdaq
  • Market Cap
  • GPCR 1.6B
  • WABC 1.3B
  • IPO Year
  • GPCR 2023
  • WABC N/A
  • Fundamental
  • Price
  • GPCR $23.77
  • WABC $49.20
  • Analyst Decision
  • GPCR Strong Buy
  • WABC Hold
  • Analyst Count
  • GPCR 7
  • WABC 3
  • Target Price
  • GPCR $81.29
  • WABC $57.00
  • AVG Volume (30 Days)
  • GPCR 752.3K
  • WABC 106.9K
  • Earning Date
  • GPCR 03-07-2025
  • WABC 04-17-2025
  • Dividend Yield
  • GPCR N/A
  • WABC 3.58%
  • EPS Growth
  • GPCR N/A
  • WABC N/A
  • EPS
  • GPCR N/A
  • WABC 5.20
  • Revenue
  • GPCR N/A
  • WABC $293,248,000.00
  • Revenue This Year
  • GPCR N/A
  • WABC N/A
  • Revenue Next Year
  • GPCR N/A
  • WABC N/A
  • P/E Ratio
  • GPCR N/A
  • WABC $9.47
  • Revenue Growth
  • GPCR N/A
  • WABC N/A
  • 52 Week Low
  • GPCR $22.33
  • WABC $44.80
  • 52 Week High
  • GPCR $62.74
  • WABC $59.97
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 37.89
  • WABC 37.74
  • Support Level
  • GPCR $22.33
  • WABC $49.01
  • Resistance Level
  • GPCR $25.17
  • WABC $50.63
  • Average True Range (ATR)
  • GPCR 1.73
  • WABC 1.05
  • MACD
  • GPCR -0.37
  • WABC -0.07
  • Stochastic Oscillator
  • GPCR 15.94
  • WABC 6.62

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.

About WABC Westamerica Bancorporation

Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California, and all the way east to Nevada County.

Share on Social Networks: